Skip to content
Trial Eligibility
Menu

Multi-Omics for Maternal Health After Preeclampsia

NCT06340152

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Pre-Eclampsia
  • Pregnancy Induced Hypertension

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 50 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
University of California, San Diego
Last updated on ClinicalTrials.gov
April 6, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • University of California, San Diego · San Diego, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.